C-aryl glucoside SGLT2 inhibitors and method | Patent Number 06414126

US 06414126 B1
Application Number9679027
Publication Number-
Pendency1 year, 9 months, 1 day
Filled DateOct 4, 2000
Priority DateOct 12, 1999
Publication Date-
Expiration DateOct 12, 2019
Inventor/ApplicantsBruce Ellsworth
Wei Meng
Gang Wu
William N. Washburn
Philip M. Sher
ExaminesKHARE, DEVESH
Art Unit1623
Technology Center1600
Assignments
Astrazeneca
Current
Bristol Myers Squibb
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.